Wolf Myles - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 10, 2025, Wolf Myles's relationship to Akebia Therapeutics, Inc. (AKBA) is Director, and currently has 133,381 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Wolf Myles - Insider Non-Derivative Transactions of AKBA Common Stock

Wolf Myles - Insider Non-Derivative Transactions at AKBA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Shares Owned After Transactions
Jun 11, 2025	Acquisition -- (Common Stock)	35700	133381
Jun 7, 2024	Acquisition -- (Common Stock)	30000	97681
Jun 7, 2023	Acquisition -- (Common Stock)	30000	67681